Jefferies Group's top holdings (October 2025) include SPDR SSGA Apollo IG Public & Private Credit ETF (SPY), an exchange-traded fund designed to track the performance of the S&P 500 index.

Jefferies Group operates as a global investment banking and capital markets firm. It provides a range of financial services, including advisory, sales and trading, and research, serving a diverse client base across various industries.

SPDR SSGA Apollo IG Public & Private Credit ETF (SPY)

This ETF is designed to track the performance of the S&P 500 index, offering exposure to 500 of the largest U.S. companies. It is a widely recognized benchmark for the U.S. equity market. The market capitalization for this ETF stands at $804.32M, with Jefferies Group's position currently valued at $878.65M.

Here's an overview of Jefferies Group's trades in SPDR SSGA Apollo IG Public & Private Credit ETF:

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF (IWM)

This ETF focuses on the Russell 2000 Index, which measures the performance of the small-capitalization segment of the U.S. equity market. It provides investors with broad exposure to smaller U.S. companies. The company's market cap stands at $3.04B, while the current value of Jefferies Group's holding is $205.45M.

Here's an overview of Jefferies Group's trades in BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF:

Invesco Capital Management LLC - Invesco QQQ Trust Series 1 (QQQ)

The Invesco QQQ Trust Series 1 is an exchange-traded fund that tracks the Nasdaq-100 Index. This index includes 100 of the largest domestic and international non-financial companies listed on the Nasdaq Stock Market. QQQ has a market capitalization of $15.29M, with Jefferies Group's position currently valued at $158.08M.

Here's an overview of Jefferies Group's trades in Invesco Capital Management LLC - Invesco QQQ Trust Series 1:

SPDR Series Trust - SPDR Biotech ETF (XBI)

The SPDR Biotech ETF seeks to provide investment results that correspond generally to the price and yield performance of the S&P Biotechnology Select Industry Index. This ETF offers exposure to the biotechnology sub-industry. The current value of Jefferies Group's position in this holding is $143.47M, and its market cap is $9.2M.

Here's an overview of Jefferies Group's trades in SPDR Series Trust - SPDR Biotech ETF:

uniQure N.V. (QURE)

uniQure N.V. is a biopharmaceutical company focused on developing gene therapies. The company is involved in the research and development of treatments for severe genetic diseases. uniQure N.V. has a market capitalization of $2.98B, with Jefferies Group's position currently valued at $122.34M. Analysts have set a price target of $59.25 for uniQure N.V. Additionally, the company's discounted cash flow analysis suggests a value of $-8.34 per share.

Here's an overview of Jefferies Group's trades in uniQure N.V.: